Susnerwala S S, Pande S C, Dinshaw K A, Advani S H, Suraiya J N
Cancer Treat Res. 1993;62:365-9. doi: 10.1007/978-1-4615-3518-8_46.
This is a report on the management of 210 patients with biopsy-proven OS seen at the Tata Memorial Hospital, Bombay, India from January 1985 to December 1988. The treatment administered to these patients reflects the constraints experienced in cancer management by developing nations. The small number of patients who received neoadjuvant chemoradiotherapy showed the highest survival figures of 30% at 5 years. In the context of the developing countries, limitations of affordability of optimum chemotherapy and the lack of adequate monitoring and support facilities warrant modifications in the currently recommended therapy schedule to suit indigenous needs.
这是一份关于1985年1月至1988年12月期间在印度孟买塔塔纪念医院就诊的210例经活检证实为骨肉瘤患者的管理报告。对这些患者实施的治疗反映了发展中国家在癌症管理中所面临的限制。接受新辅助放化疗的患者数量较少，其5年生存率最高，为30%。在发展中国家的背景下，最佳化疗的可负担性限制以及缺乏足够的监测和支持设施，使得有必要对目前推荐的治疗方案进行调整，以适应本土需求。
